Pharma bureau urges public to stop using ‘LAB LUMINUS ANTI-SENSITIVE SERUM’

2022-10-17 03:23
BY Yuki Lei
Comment:0

The Pharmaceutical Supervision and Administration Bureau (ISAF) urged the public on Friday to stop using a topical product named “LAB LUMINUS ANTI-SENSITIVE SERUM” as it was found to have the medicine ingredient “betamethasone valerate”.

An ISAF statement noted that the bureau has not approved the import of the product and it therefore is not supposed to be available in the local market.

According to the statement, “betamethasone valerate” is a steroid used to treat inflammation under prescription. The statement added that the side effects of the drug include facial oedema (aka face swelling), high blood pressure, hyperglycaemia (high blood sugar), skin atrophy, adrenal insufficiency and osteoporosis.

In order to protect public health, the bureau will closely monitor the appearance of the product in Macau, according to the statement.

The statement underlined that those who have bought the product should immediately stop using it and send it to the bureau in China Plaza on Avenida de Sidónio Pais.

Enquiries can be made by calling 8598 3533 during office hours. 


This undated handout photo provided by the Pharmaceutical Administration Bureau (ISAF) on Friday shows the “LAB LUMINUS ANTI-SENSITIVE SERUM” topical product containing betamethasone valerate.


0 COMMENTS

Leave a Reply